Previous controversial studies emerged regarding the prognostic value of AhR or GPR30 expression levels in breast cancers (71, 73, 80–84), and these discrepancies have been suggested as possibly related to the breast cancer subgroup or the substage considered. This evidence concerns the gene GPER1 and breast cancer.